Key result
Improved diastolic function at 6 months is linked to ~68% fewer deaths, transplants, and HF hospitalizations.
Why the study?
The clinical course and prognostic significance of temporal changes in diastolic function in patients with recent onset non-ischaemic cardiomyopathy were not well understood.
Cohort (n=147)
Yes
Improvement in diastolic function at 6 months provides incremental prognostic value beyond LVEF recovery in patients with recent-onset non-ischemic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Diastolic improvement may refine HF risk stratification; leaves open whether it is a modifiable target.
AIMS: Patients with recent onset non-ischaemic cardiomyopathy have a variable clinical course with respect to recovery of left ventricular ejection fraction (LVEF). The aim of this study was to understand whether temporal changes in diastolic function (DF) are associated with clinical outcomes independent of LVEF recovery. METHODS AND RESULTS: The Intervention in Myocarditis and Acute Cardiomyopathy (IMAC)-2 study was a prospective, multicentre trial investigating myocardial recovery in subjects with symptoms onset of <6 months and LVEF ≤40% of non-ischaemic dilated cardiomyopathy related to idiopathic cardiomyopathy or myocarditis. LVEF and DF were measured at presentation and at 6-month follow-up. Of 147 patients (mean age 46 ± 14 years, 40% female), baseline LVEF was 23 ± 8%. At 6 months, LVEF improved to 41 ± 12%, with 71% increasing by at least 10% ejection fraction units. DF improved in 58%, was unchanged in 28%, and worsened in 14%. Over a mean follow-up of 1.8 ± 1.2 years, there were 18 events: 11 heart failure (HF) hospitalizations, 3 deaths, and 4 heart transplants. LVEF (HR = 0.94, 95% CI 0.91-0.98, P = 0.002) and DF improvements at 6 months (HR = 0.32, 95% CI 0.11-0.92, P = 0.03) were independently associated with lower likelihood for the combined end point of death, transplantation, and HF hospitalization. Diastolic functional improvement at 6-month follow-up was as prognostically important as LVEF recovery for these patients, and provided incremental prognostic value to the risk stratification (X(2) increased from 12.6 to 18, P = 0.02). CONCLUSION: In patients with recent onset non-ischaemic cardiomyopathy, DF recovery was associated with favourable outcomes independent of LVEF improvement, adding incremental prognostic value to these patients.
No takes yet. Share an insight, caveat, or question.
Cavalcante et al. (2015) conducted a cohort in recent onset non-ischaemic cardiomyopathy (n=147). Diastolic function improvement at 6 months vs. No diastolic function improvement was evaluated on combined end point of death, transplantation, and HF hospitalization (HR 0.32, 95% CI 0.11-0.92, p=0.03). Diastolic function improvement at 6 months was independently associated with a lower likelihood of death, transplantation, and heart failure hospitalization.
Synapse has enriched 10 related papers. Consider them for comparative context: